-transparent.png){kind=logo}
Cyclic nucleotide phosphodiesterase activity has been measured in muscle biopsies taken from healthy controls and from cancer patients. In both groups the muscles were clinically and morphologically normal. The phosphodiesterase activity was significantly increased in muscles from cancer patients using both cyclic AMP and cyclic GMP as substrate. These findings are in line with previous reports indicating that malignancy may interfere with metabolism of the host muscular tissues, and suggest the possibility that the observed biochemical changes might be an aspect of an early muscle neurogenic involvement.
Related Publications
N Canal, and
C Cerri, and
L Frattola, and
M Trabucchi
January 1977,
Biology of the neonate,
N Canal, and
C Cerri, and
L Frattola, and
M Trabucchi
January 1982,
Allergologia et immunopathologia,
N Canal, and
C Cerri, and
L Frattola, and
M Trabucchi
January 1981,
Advances in cyclic nucleotide research,
N Canal, and
C Cerri, and
L Frattola, and
M Trabucchi
January 1998,
Cell biochemistry and biophysics,
N Canal, and
C Cerri, and
L Frattola, and
M Trabucchi
September 1973,
Plant physiology,
N Canal, and
C Cerri, and
L Frattola, and
M Trabucchi
January 1997,
World journal of urology,
N Canal, and
C Cerri, and
L Frattola, and
M Trabucchi
February 1978,
Thrombosis and haemostasis,
N Canal, and
C Cerri, and
L Frattola, and
M Trabucchi
November 2005,
Canadian journal of physiology and pharmacology,
N Canal, and
C Cerri, and
L Frattola, and
M Trabucchi
January 1970,
Advances in biochemical psychopharmacology,
N Canal, and
C Cerri, and
L Frattola, and
M Trabucchi
January 1976,
Nature,
